Comment of an Expert Group of the Paul-Ehrlich-Society for Chemotherapy on the benefit assessment of fidaxomicin for treatment of Clostridium difficile infections
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
German Medical Science GMS Publishing House
2013-11-01
|
| Series: | GMS Infectious Diseases |
| Online Access: | http://www.egms.de/static/en/journals/id/2013-1/id000007.shtml |
| id |
doaj-a31f15f5185046f6b8a444547470de5a |
|---|---|
| record_format |
Article |
| spelling |
doaj-a31f15f5185046f6b8a444547470de5a2020-11-25T02:40:24ZengGerman Medical Science GMS Publishing HouseGMS Infectious Diseases2195-88312013-11-011Doc0710.3205/id000007Comment of an Expert Group of the Paul-Ehrlich-Society for Chemotherapy on the benefit assessment of fidaxomicin for treatment of Clostridium difficile infectionsKresken, Michael0von Müller, Lutz1Grabein, Béatrice2Herrmann, Mathias3Höffken, Gert4Hoerauf, Achim5Kern, Peter6Pletz, Mathias W.7Reisinger, Emil8Cornely, Oliver A.9Groll, Andreas H.10Antiinfectives Intelligence GmbH, Rheinbach, GermanyInstitut für Medizinische Mikrobiologie und Hygiene, Universitätsklinikum des Saarlandes, Homburg/Saar, GermanyKlinikum der Universität München, Munich, GermanyInstitut für Medizinische Mikrobiologie und Hygiene, Universitätsklinikum des Saarlandes, Homburg/Saar, GermanyMedizinische Klinik I, Universitätsklinikum Carl Gustav Carus, Dresden, GermanyInstitut für Medizinische Mikrobiologie, Immunologie und Parasitologie, Universitätsklinikum Bonn, GermanyUniversitätsklinikum Ulm, GermanyZentrum für Infektionsmedizin und Krankenhaushygiene, Universitätsklinikum Jena, GermanyUniversitätsmedizin Rostock, GermanyKlinik I für Innere Medizin, Uniklinik Köln, Cologne, GermanyKlinik für Kinder- und Jugendmedizin, Pädiatrische Hämatologie und Onkologie, Universitätsklinikum Münster, Germanyhttp://www.egms.de/static/en/journals/id/2013-1/id000007.shtml |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Kresken, Michael von Müller, Lutz Grabein, Béatrice Herrmann, Mathias Höffken, Gert Hoerauf, Achim Kern, Peter Pletz, Mathias W. Reisinger, Emil Cornely, Oliver A. Groll, Andreas H. |
| spellingShingle |
Kresken, Michael von Müller, Lutz Grabein, Béatrice Herrmann, Mathias Höffken, Gert Hoerauf, Achim Kern, Peter Pletz, Mathias W. Reisinger, Emil Cornely, Oliver A. Groll, Andreas H. Comment of an Expert Group of the Paul-Ehrlich-Society for Chemotherapy on the benefit assessment of fidaxomicin for treatment of Clostridium difficile infections GMS Infectious Diseases |
| author_facet |
Kresken, Michael von Müller, Lutz Grabein, Béatrice Herrmann, Mathias Höffken, Gert Hoerauf, Achim Kern, Peter Pletz, Mathias W. Reisinger, Emil Cornely, Oliver A. Groll, Andreas H. |
| author_sort |
Kresken, Michael |
| title |
Comment of an Expert Group of the Paul-Ehrlich-Society for Chemotherapy on the benefit assessment of fidaxomicin for treatment of Clostridium difficile infections |
| title_short |
Comment of an Expert Group of the Paul-Ehrlich-Society for Chemotherapy on the benefit assessment of fidaxomicin for treatment of Clostridium difficile infections |
| title_full |
Comment of an Expert Group of the Paul-Ehrlich-Society for Chemotherapy on the benefit assessment of fidaxomicin for treatment of Clostridium difficile infections |
| title_fullStr |
Comment of an Expert Group of the Paul-Ehrlich-Society for Chemotherapy on the benefit assessment of fidaxomicin for treatment of Clostridium difficile infections |
| title_full_unstemmed |
Comment of an Expert Group of the Paul-Ehrlich-Society for Chemotherapy on the benefit assessment of fidaxomicin for treatment of Clostridium difficile infections |
| title_sort |
comment of an expert group of the paul-ehrlich-society for chemotherapy on the benefit assessment of fidaxomicin for treatment of clostridium difficile infections |
| publisher |
German Medical Science GMS Publishing House |
| series |
GMS Infectious Diseases |
| issn |
2195-8831 |
| publishDate |
2013-11-01 |
| url |
http://www.egms.de/static/en/journals/id/2013-1/id000007.shtml |
| work_keys_str_mv |
AT kreskenmichael commentofanexpertgroupofthepaulehrlichsocietyforchemotherapyonthebenefitassessmentoffidaxomicinfortreatmentofclostridiumdifficileinfections AT vonmullerlutz commentofanexpertgroupofthepaulehrlichsocietyforchemotherapyonthebenefitassessmentoffidaxomicinfortreatmentofclostridiumdifficileinfections AT grabeinbeatrice commentofanexpertgroupofthepaulehrlichsocietyforchemotherapyonthebenefitassessmentoffidaxomicinfortreatmentofclostridiumdifficileinfections AT herrmannmathias commentofanexpertgroupofthepaulehrlichsocietyforchemotherapyonthebenefitassessmentoffidaxomicinfortreatmentofclostridiumdifficileinfections AT hoffkengert commentofanexpertgroupofthepaulehrlichsocietyforchemotherapyonthebenefitassessmentoffidaxomicinfortreatmentofclostridiumdifficileinfections AT hoeraufachim commentofanexpertgroupofthepaulehrlichsocietyforchemotherapyonthebenefitassessmentoffidaxomicinfortreatmentofclostridiumdifficileinfections AT kernpeter commentofanexpertgroupofthepaulehrlichsocietyforchemotherapyonthebenefitassessmentoffidaxomicinfortreatmentofclostridiumdifficileinfections AT pletzmathiasw commentofanexpertgroupofthepaulehrlichsocietyforchemotherapyonthebenefitassessmentoffidaxomicinfortreatmentofclostridiumdifficileinfections AT reisingeremil commentofanexpertgroupofthepaulehrlichsocietyforchemotherapyonthebenefitassessmentoffidaxomicinfortreatmentofclostridiumdifficileinfections AT cornelyolivera commentofanexpertgroupofthepaulehrlichsocietyforchemotherapyonthebenefitassessmentoffidaxomicinfortreatmentofclostridiumdifficileinfections AT grollandreash commentofanexpertgroupofthepaulehrlichsocietyforchemotherapyonthebenefitassessmentoffidaxomicinfortreatmentofclostridiumdifficileinfections |
| _version_ |
1724781784957190144 |